Obesity Reduces Maternal Blood Triglyceride Concentrations by Reducing Angiopoietin-Like Protein 4 Expression in Mice
Open Access
- 12 February 2020
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 69 (6) , 1100-1109
Abstract
To ensure fetal lipid supply, maternal blood triglyceride (TG) concentrations are robustly elevated during pregnancy. Interestingly, a lower increase in maternal blood TG concentrations has been observed in some obese mothers. We have shown that high-fat (HF) feeding during pregnancy significantly reduces maternal blood TG levels. Therefore, we performed this study to investigate if and how obesity alters maternal blood TG levels. Maternal obesity was established by prepregnant HF (ppHF) feeding, which avoided the dietary effect during pregnancy. We found not only that maternal blood TG concentrations in ppHF dams were remarkably lower than in control dams but also that the TG peak occurred earlier during gestation. Hepatic TG production and intestinal TG absorption were unchanged in ppHF dams, but systemic lipoprotein lipase (LPL) activity was increased, suggesting that increased blood TG clearance contributes to the decreased blood TG concentrations in ppHF dams. Although significantly higher levels of UCP1 protein were observed in interscapular brown adipose tissue (iBAT) of ppHF dams, Ucp1 gene deletion did not restore blood TG concentrations in ppHF dams. Expression of the angiopoietin-like protein 4 (ANGPTL4), a potent endogenous LPL inhibitor, was significantly increased during pregnancy. However, the pregnancy-induced elevation of blood TG was almost abolished in Angptl4−/− dams. Compared with control dams, Angptl4 mRNA levels were significantly lower in iBAT, gonadal white adipose tissue, and livers of ppHF dams. Importantly, ectopic overexpression of ANGPTL4 restored maternal blood TG concentrations in ppHF dams. Together, these results indicate that ANGPTL4 plays a vital role in increasing maternal blood TG concentrations during pregnancy. Obesity impairs the rise of maternal blood TG concentrations by reducing ANGPTL4 expression in mice.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (HL-130146)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-095132, DK-113007)
- ADA Foundation (1–16-IBS-272)
This publication has 51 references indexed in Scilit:
- Atypical angiopoietin-like protein that regulates ANGPTL3Proceedings of the National Academy of Sciences, 2012
- Adverse Fetal and Neonatal Outcomes Associated with a Life-Long High Fat Diet: Role of Altered Development of the Placental VasculaturePLOS ONE, 2012
- Continuous Glucose Profiles in Obese and Normal-Weight Pregnant Women on a Controlled DietDiabetes Care, 2011
- Genetic Variation in ANGPTL4 Provides Insights into Protein Processing and FunctionJournal of Biological Chemistry, 2009
- Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humansJournal of Clinical Investigation, 2008
- Maternal Lipids as Strong Determinants of Fetal Environment and Growth in Pregnancies With Gestational Diabetes MellitusDiabetes Care, 2008
- Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride CatabolismDiabetes, 2008
- Fasting-induced adipose factor identified as a key adipokine that is up-regulated in white adipose tissue during pregnancy and lactation in the ratJournal of Endocrinology, 2007
- Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissueProceedings of the National Academy of Sciences, 2006
- Lipoprotein lipase activity of adipose and mammary tissue and plasma triglyceride in pregnant and lactating ratsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1970